Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant

NCT05260268 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT05260268
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05260268 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant
Lead sponsor
University of Pennsylvania
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 1, 2022
Completion date
April 1, 2027
Enrollment
361 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, end stage liver disease, liver transplant; complications, medication adherence